# SCRIMED p.34 Review Packet

Status: local implementation evidence is complete; exact commit and release-evidence fingerprints must be generated after the focused local commit and reviewed without substitution.

## Review Lanes

- Technical: typed contracts, deterministic decisions, bounded errors, route/API/UI integration, tests, and build.
- Clinical safety: decision-support boundary, missing/conflicting evidence, clinical review, continuity interpretation, and hard quality floors.
- Privacy/security: tenant and data-class boundaries, approval binding, replay protection, telemetry redaction, DICOM quarantine, and cache identity.
- Platform/model governance: provider portability, local evaluation evidence, outage handling, context/cost/latency admission, challenger isolation, and safe refusal.
- Operations/value: named workflow owner, baseline/KPIs, action rollback, continuity queues, verified outcomes, and expansion thresholds.
- Claims/legal/public sector: primary documentary evidence, wording, expiry, licensing, publication permission, and prohibited compliance/eligibility claims.

Reviewer approval must name the exact commit, candidate fingerprint, source fingerprint, validation fingerprint, review-packet fingerprint, gate-packet fingerprint, scope, decision, conditions, timestamp, and expiry. A template, verbal approval, public benchmark, or prior-candidate approval is not a passing gate.

## Review Evidence

| Lane | Local evidence | Required external disposition |
| --- | --- | --- |
| Technical | 40/40 existing policy checks, 27/27 new negative-path checks, 67/67 contracts, typecheck, lint, build, route inventory, and generated integrity passed | Named technical review of the exact commit |
| Clinical safety | Missing/stale evidence, unsafe PHI route, unauthorized system write, and noncausal continuity boundaries passed | Qualified clinical-safety review before clinical-facing external use or cohort expansion |
| Privacy/security | 1,728-file secret scan with zero findings; approval replay, duplicate execution, PHI routing, telemetry redaction, and cross-tenant continuity tests passed | Privacy/security review; existing account-security operator warning remains retained |
| Platform/model governance | Provider failure, local evidence, deterministic-first selection, context floors, and public-rank exclusion passed | Documentary provider, license, BAA/product-path, residency, and infrastructure evidence before applicable activation |
| Operations/value | Workflow contract, rollback, continuity transfer, expansion threshold, and ROI evidence passed | Named operational owner plus exact pilot cohort/duration and approval evidence |
| Claims/legal/public sector | Public-sector and challenger profiles fail closed without documentary evidence | Counsel/claims and procurement review before any external claim or eligibility statement |

## Exact Local Results

- Direct quality runner: 10/10 gates passed on consecutive final-tree runs.
- Full nonsecret suite: passed; 274 registered package scripts and 10 CI workflows verified.
- p.34 artifacts: 2/2 intact; validation report 20/20.
- Build output: 628 routes; built public-release verifier passed.
- Desktop/mobile UI: 1280x800 and 390x844, no overflow, overlays, warnings, or errors.
- New local APIs: workflow, model-fit, actions, continuity, public-sector, challengers, and ROI returned HTTP 200.
- SBOM: 422 components; no dependency delta.
- Database: no p.34 migration; three pre-existing pending migrations remain unapplied and require separately authorized disposable-database validation.

Approval of this code does not authorize PHI, clinical authority, provider calls, external writes, pilot expansion, challenger promotion, public-sector claims, migration, deployment, distribution, or customer activation.
